PaySign And 3 Other Stocks Under $3 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at PaySign, Retractable Technologies, Tecogen, and Vivani Medical have recently made notable purchases of their companies' stocks. PaySign's 10% owner acquired shares at $2.79 each, Retractable Technologies' CEO and President bought shares at $1.22 each, Tecogen's Director purchased shares at $0.78 each, and Vivani Medical's Director bought shares at $1.01 each. These transactions can signal insider confidence and may influence investor decisions, especially those interested in penny stocks.

January 26, 2024 | 1:52 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Retractable Technologies' CEO and President Thomas J Shaw acquired 5,539 shares at $1.22 each despite the company reporting an $8.7 million loss from operations for the first nine months of 2023.
The insider purchase by the CEO and President of Retractable Technologies may be seen as a positive sign, but the recent report of a significant loss could temper any potential stock price increase.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Vivani Medical's Director Gregg Williams acquired 834 shares at $1.01 each after the company reported a wider-than-expected quarterly loss.
The insider purchase by Vivani Medical's Director could be a sign of confidence in the company's long-term prospects, but the recent wider-than-expected loss may limit any positive impact on the stock price in the short term.
CONFIDENCE 60
IMPORTANCE 55
RELEVANCE 65
POSITIVE IMPACT
PaySign's 10% owner Topline Capital Partners LP purchased 107,157 shares at $2.79 each, signaling potential insider confidence following better-than-expected quarterly sales in November.
The insider purchase by PaySign's 10% owner suggests confidence in the company's future, especially after reporting better-than-expected sales. This could positively influence the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Tecogen Inc.'s Director Earl R Lewis bought 9,152 shares at $0.78 each, following the company's announcement of a significant order for its Tecochill unit.
The insider purchase by Tecogen's Director comes after a positive announcement about a new order, which could indicate potential growth and a positive short-term impact on the stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75